Worm.com

Guide to Spyware and AntiVirus Information

You are currently browsing the Worm.com weblog archives for February, 2008.

 

February 2008
M T W T F S S
« Jan   Mar »
 123
45678910
11121314151617
18192021222324
2526272829  

Sponsors

Archive for February, 2008

M2 PRESSWIRE-29 February 2008-Kaspersky Lab: Kaspersky Lab announces the release of maintenance pack 1 for Kaspersky Anti-Virus for Windows Server Enterprise Edition; Improvements make it easier for system administrators to connect and monitor status of antivirus protection installed on the server(C)1994-2008 M2 COMMUNICATIONS LTD

RDATE:29022008

Kaspersky Lab, a leading provider of security solutions that protect against viruses, Trojans, worms, spyware, crimeware, rootkits, phishing, hacker attacks and spam, today announces the release of Maintenance Pack 1 for Kaspersky …

Read the rest of this article with a Free Trial at HighBeam Research.

Information provided by: Findarticles.com

Share and Enjoy:
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google
  • Reddit
  • Slashdot
  • Spurl
  • Technorati
  • TwitThis

A gene in Asian monkeys that may have evolved as protection against a group of viruses that includes HIV has been identified by Harvard Medical School researchers, who add that their finding suggests the current AIDS epidemic is not a new kind of scourge.

The TRIM5-CypA gene found in Asian macaques is a hybrid of two existing proteins, TRIM5 and CypA. This combination creates a single protein that blocks infections by lentiviruses.

TRIMCyp — was found in South American owl monkeys in 2004. But it’s not likely that these two gene combinations arose from a single common ancestor, the Harvard researchers said.

TRIM5-CypA wasn’t found in monkey closely related to the Asian macaques and TRIMCyp wasn’t found in any other South American primate species. This suggests that the two combination genes evolved separately, once in the macaques and once in the owl …


Read the full article with a Free Trial at MyWire.

Information provided by: Findarticles.com

Share and Enjoy:
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google
  • Reddit
  • Slashdot
  • Spurl
  • Technorati
  • TwitThis

M2 PRESSWIRE-29 February 2008-Network Box: USA maintains virus and spam top spot in February, according to monthly Network Box Threat Analysis

(C)1994-2008 M2 COMMUNICATIONS LTD

RDATE:29022008

London- The US continues to pump out the most spam and spread the most viruses, according to threat statistics analysed in February by managed security company, Network Box. The country accounted for 13 per cent of all viruses; and was the source of 15 per cent of all spam, more than double its closest rival, Turkey.

Korea topped the intrusion chart for the third month running, …

Read the rest of this article with a Free Trial at HighBeam Research.

Information provided by: Findarticles.com

Share and Enjoy:
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google
  • Reddit
  • Slashdot
  • Spurl
  • Technorati
  • TwitThis

SAN JOSE, Calif. — F-Secure, a global leader in providing IT security solutions to small and medium-sized companies, today announced the launch of the latest version of its F-Secure[R] Anti-Virus[TM] for Windows Servers solution, version 8. F-Secure Anti-Virus for Windows Servers version 8 features several significant performance improvements. Version 8 features F-Secure’s new scanning technology, which is capable of meeting the rapidly evolving and more targeted malware threat scenarios better than ever. Extensive testing of the beta version of the software also shows that the memory consumption of version 8 is, on average, up to 50 percent less than in the previous version.

Significant performance improvements in the solution enable companies to safeguard their Windows servers with a better level of protection and lower resource use compared to earlier versions. F-Secure Anti-Virus for Windows Servers version 8 provides real-time protection against viruses, spyware and riskware, and prevents infections from spreading across a company’s network.

F-Secure Anti-Virus for Windows Servers version 8 supports Microsoft Windows Server 2008, which is set to be one of the major software releases from Microsoft this year. F-Secure believes that Microsoft Windows Server 2008 will soon become an important part of the corporate IT infrastructure worldwide. F-Secure is committed to providing first class security solutions with clear added value for Microsoft server platforms.

With F-Secure, anti-virus protection is fast, efficient and easy. Installations and management can be performed remotely from a single central location, saving cost and time for IT departments.

More than 1,300 new virus detections are found each day at the F-Secure Labs, and some of these have the potential of spreading globally within hours. If a virus enters a corporate network, fighting it can prove to be both difficult and time consuming. Virus infections often result in significant financial losses due to network disruptions, decreased productivity, corrupted data and the leaking of confidential data. Even a company’s reputation can be in danger if it unwittingly spreads viruses to its business associates.

F-Secure Anti-Virus for Windows Servers version 8 is an excellent security solution for companies that seek to protect their Microsoft server platforms with a centrally managed, efficient solution providing the highest level of security, but requiring less system resources. Deliveries of the solution will start in late April 2008.

About F-Secure Corporation

F-Secure Corporation protects consumers and businesses against computer viruses and other threats from the Internet and mobile networks. F-Secure’s award-winning solutions are available as a service subscription through more than 160 Internet service provider and mobile operator partners around the world, making F-Secure the global leader in this market. The solutions are also available as licensed products through thousands of resellers globally. The company aspires to be the most reliable security provider, helping make computer and smartphone users’ connected lives safe and easy. This is substantiated by the company’s independently proven ability to respond faster to new threats than its main competitors. Founded in 1988, and headquartered in Finland, F-Secure has been listed on the OMX Nordic Exchange Helsinki 1999. The company has consistently been one of the fastest growing publicly listed companies in the industry. The latest news on real-time virus threat scenarios is available at the F-Secure Data Security Lab weblog at http://www.f-secure.com/weblog/

COPYRIGHT 2008 Business Wire
COPYRIGHT 2008 Gale, Cengage Learning

Information provided by: Findarticles.com

Share and Enjoy:
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google
  • Reddit
  • Slashdot
  • Spurl
  • Technorati
  • TwitThis

An experimental combination vaccine that uses so-called virus-like particles (VLPs) fully protected monkeys against the deadly Ebola and Marburg viruses, U.S. researchers say.

Ebola and Marburg are viral hemorrhagic fevers, the only two known members of the filovirus family of viruses, according to the U.S. Centers for Disease Control and Prevention. These often fatal infections have triggered highly publicized outbreaks in Africa over the past few decades.

“VLPs are one of the most promising candidates for protecting humans against Ebola and Marburg virus infections,” and could be safer than other vaccine candidates, researcher Dr. Kelly Warfield, of the U.S. Army Medical Research Institute of Infectious Diseases, said in a prepared statement.

either dead or weakened versions of the virus that causes the disease or a virus that’s genetically similar to the one that causes the disease. But these vaccines do carry a slight risk of …


Read the full article with a Free Trial at MyWire.

Information provided by: Findarticles.com

Share and Enjoy:
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google
  • Reddit
  • Slashdot
  • Spurl
  • Technorati
  • TwitThis

DUBAI (AFP) — Maria Sharapova, who won the Qatar Open only two days ago, has pulled out of the Dubai Open here with a virus.

The Australian Open champion from Russia was said to be suffering from the problem last week and complained of losing energy in the second second of her three-set win over Vera Zvonareva in Sunday’s final in Doha.

“Unfortunately I have been battling a virus for several days and it’s reached a point where I’m unable to compete. It’s really disappointing,” said Sharapova.

Sharapova will be replaced in the Dubai draw by a lucky loser, Akiko Morigami, the world number 50 from Japan.

It’s particularly disappointing for the Russian because, having remained unbeaten in 14 matches this year, Sharapova appears to have been in some of the best form of her life.

During this time she has dropped only one …


Read the full article with a Free Trial at MyWire.

Information provided by: Findarticles.com

Share and Enjoy:
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google
  • Reddit
  • Slashdot
  • Spurl
  • Technorati
  • TwitThis

SAN DIEGO (AP) — A highly contagious virus sickened more than 100 passengers on a Holland America cruise ship that returned to San Diego Monday from a 10-day trip to Mexico.

Passengers on the Ryndam ship first showed signs of the norovirus six days into the trip, said Erik Elvejord, a spokesman for Holland America Line Inc. The virus causes nausea, vomiting and diarrhea and lasts 24 to 48 hours.

The virus sickened 104 passengers and six crew members, Elvejord said. The ship was carrying 1,226 passengers and 556 crew members. It visited several ports in Mexico’s Sea of Cortez after leaving San Diego Feb. 15.

Copyright C 2008 Deseret News Publishing Co.
Provided by ProQuest Information and Learning Company. All rights Reserved.

Information provided by: Findarticles.com

Share and Enjoy:
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google
  • Reddit
  • Slashdot
  • Spurl
  • Technorati
  • TwitThis

CAMBRIDGE, Mass. — Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that it will host a conference call to discuss the full results from the Phase II GEMINI study of ALN-RSV01, being presented at the International Symposium on Respiratory Viral Infections in Singapore. The webcast will take place on Friday, February 29, 2008 at 8:30 a.m. ET.

To access the call, please dial 888-396-2384 (domestic) or 617-847-8711 (international) five minutes prior to the start time and provide the passcode 86570853. A replay of the call will be available from 10:30 a.m. ET on February 29, 2008 until March 7, 2008. To access the replay, please dial 888-286-8010 (domestic) or 617-801-6888 (international), and provide the passcode 79263826.

A live audio webcast of the call will also be available on the "Investors" section of the company’s website, www.alnylam.com. An archived webcast will be available on the Alnylam website approximately two hours after the event and will be archived for 14 days.

About Alnylam

Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. The company is applying its therapeutic expertise in RNAi to address significant medical needs, many of which cannot effectively be addressed with small molecules or antibodies, the current major classes of drugs. Alnylam is leading the translation of RNAi as a new class of innovative medicines with peer-reviewed research efforts published in the world’s top scientific journals including Nature, Nature Medicine, and Cell. The company is leveraging these capabilities to build a broad pipeline of RNAi therapeutics; its most advanced program is in Phase II human clinical trials for the treatment of respiratory syncytial virus (RSV) infection. In addition, the company is developing RNAi therapeutics for the treatment of a wide range of disease areas, including hypercholesterolemia, liver cancers, and Huntington’s disease. The company’s leadership position in fundamental patents, technology, and know-how relating to RNAi has enabled it to form major alliances with leading companies including Medtronic, Novartis, Biogen Idec, and Roche. To reflect its outlook for key scientific, clinical, and business initiatives, Alnylam has established "RNAi 2010" which includes the company’s plan to significantly expand the scope of delivery solutions for RNAi therapeutics, have four or more programs in clinical development, and to form four or more new major business collaborations, all by the end of 2010. Alnylam is a joint owner of Regulus Therapeutics LLC, a joint venture focused on the discovery, development, and commercialization of microRNA therapeutics. Founded in 2002, Alnylam maintains headquarters in Cambridge, Massachusetts. For more information, visit www.alnylam.com.

COPYRIGHT 2008 Business Wire
COPYRIGHT 2008 Gale, Cengage Learning

Information provided by: Findarticles.com

Share and Enjoy:
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google
  • Reddit
  • Slashdot
  • Spurl
  • Technorati
  • TwitThis

M2 PRESSWIRE-21 February 2008-Yale University: Yale Lab Engineers Virus That Can Kill Deadly Brain Tumors; glioblastoma Human glioblastoma cells with red fluorescent protein(C)1994-2008 M2 COMMUNICATIONS LTD

RDATE:21022008

New Haven, Conn. — A laboratory-engineered virus that can find its way through the vascular system and kill deadly brain tumors has been developed by Yale School of Medicine researchers, it was reported this week in the Journal of Neuroscience.

Each year 200,000 people in the United States are diagnosed with a brain tumor, and metastatic tumors and …

Read the rest of this article with a Free Trial at HighBeam Research.

Information provided by: Findarticles.com

Share and Enjoy:
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google
  • Reddit
  • Slashdot
  • Spurl
  • Technorati
  • TwitThis

BARCELONA, Spain (AFP) — Viruses and hacking on mobile phones are still rare but attacks are a looming danger as increasing numbers of people access the Internet and download files with their handsets, experts say.

A survey released this week at the industry’s Mobile World Congress showed that only 2.1 percent of people had been struck by a virus themselves and only 11.6 percent knew someone who had been affected by one.

The poll by IT security specialist McAfee, based on 2,000 people in Britain, the United States and Japan, showed that 86.3 percent had had no experience of mobile phone viruses.

The survey did suggest however that the more developed the mobile market is, with high use of the Internet and downloads, the more likely people were to be hit by bugs.

Virus attacks in Japan, the most developed mobile phone market in the …


Read the full article with a Free Trial at MyWire.

Information provided by: Findarticles.com

Share and Enjoy:
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google
  • Reddit
  • Slashdot
  • Spurl
  • Technorati
  • TwitThis